🇮🇳·15h agoIndustry
disclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015
Publisher
N
Natco Pharma
India
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on natcopharma.co.in
Leave the platform to read the original full article on the publisher site.
Source: Natco Pharma
Scope: Industry
Related coverage
More related coverage
Bristol-Myers Squibb News·4h ago
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026
Farmak (Ukraine)·4h ago
Farmak Named Among Ukraine’s Best Employers 2026 by Forbes Ukraine
Hyman, Phelps & McNamara (FDA Law)·13h ago
“Sounds Great. Do You Want FDA Approval?” A Regulatory Analysis of Psychedelics
Natco Pharma·15h ago